Cardiac Digital Twins: Precision Heart Models

• Cardiac Digital Twins are precise, patient-specific virtual hearts that integrate anatomical, biophysical, and functional data for enhanced diagnostics and therapy.
• They employ automated pipelines including high-resolution imaging, 3D U-Net segmentation, and robust finite element mesh generation to ensure high fidelity.
• Validated via simulation metrics and clinical comparison, CDTs advance reproducible device planning and personalized treatment strategies.

Cardiac Digital Twins (CDTs) are rigorously constructed, patient-specific virtual counterparts of the heart, integrating multiscale anatomical, biophysical, and functional data for predictive simulation, diagnosis, device planning, and therapy optimization. Central to the CDT paradigm is the replacement of generic or operator-dependent workflows with fully automated, high-fidelity, and reproducible models capable of supporting precision cardiology at individual and population scales (Pak et al., 2024).

1. Background and Motivation

Cardiac Digital Twins are envisioned as the convergence of clinical imaging, signal acquisition, and computational physics, producing platform-ready models for both research and clinical decision support (Rudnicka et al., 2024). Their realization spans multiple demanding domains:

• Anatomical fidelity—Sub-millimeter accuracy in 3D cardiac and vascular reconstructions from modalities such as cardiac CT and MR.
• Pathophysiological detail—Explicit encoding of disease substrates, e.g., calcification or infarct zones, required for realistic device, interventional, and hemodynamic modeling.
• Scalability and efficiency—Workflows must support large-scale cohort analysis and rapid clinical turnaround, removing human bottlenecks in mesh generation, parameter assignment, and validation (Pak et al., 2024).
• Reproducibility and consistency—Automated pipelines minimize operator bias and batch differences, supporting regulated medical use and longitudinal cohort tracking (Pak et al., 2024).

Traditional finite-element (FE) mesh workflows for incorporating calcification exemplify process bottlenecks—hours of expert manual segmentation and mesh repair per patient—which pose significant barriers to scale-up and clinical translation. Eliminating such bottlenecks is a cornerstone of CDT adoption and their integration into predictive modeling and device planning (Pak et al., 2024).

2. Automated Calcification Meshing: Technical Workflow

A robust, fully automated pipeline has been proposed specifically for embedding patient-specific calcification into cardiac FE meshes, transforming a multi-hour manual process into a minute-scale, reproducible computational step (Pak et al., 2024). The core workflow is outlined below:

Pipeline Stages

1. Image Preprocessing
   • Input: Contrast-enhanced cardiac CT volume $f(x)$.
   • Automated ROI extraction around the aortic root (atlas-based localization).
   • Optional noise-suppressing filtering (anisotropic diffusion or bilateral) to preserve calcium edges.
2. Calcification Segmentation
   • 3D U-Net trained to output a voxel-wise calcium probability map $p(x)\in[0,1]$.
   • Connected-component morphological filtering removes small artefacts ($<$50 voxels).
   • Level set thresholding ($\phi(x) = p(x)-\tau$, $\tau\approx0.5$) delineates the implicit calcium surface.
3. Mesh Insertion (Boolean Fusion + Retetrahedralization)
   • Marching-tetrahedra extracts the calcification surface $S_c$.
   • Robust polygon-punching boolean union with the host mesh $S_h$ (myocardium/aorta).
   • Region is retetrahedralized (TetGen), enforcing user-specified element size and quality bounds.
4. Mesh Smoothing and Quality Enforcement
   • Locally injective mapping (MIPS) energy minimization to prevent mesh inversion.
   • Area- and volume-weighted Laplacian smoothing near the tissue–calcification interface.
   • Enforce dihedral angle bounds: $20^\circ \leq \theta_t \leq 160^\circ$.

Quality Metrics

• Scaled Jacobian $q_t = \frac{6\sqrt{2} V_t}{\sum_{k=1}^6 \ell_k^3}$ per tetrahedron $t$ (where $p(x)\in[0,1]$0 is volume, $p(x)\in[0,1]$1 edge lengths).
• Dihedral angle strict bounds to avoid tiny, flat, or inverted elements.

Mathematical Formulations

• Segmentation functional

$p(x)\in[0,1]$2

• Registration/mesh fusion

$p(x)\in[0,1]$3

• Mesh-smoothing energy (MIPS)

$p(x)\in[0,1]$4

3. Implementation and Computational Advances

• Segmentation via 3D U-Net (PyTorch) with $p(x)\in[0,1]$5s inference time on a single NVIDIA GPU.
• Mesh operations (VTK, C++ wrappers) and parallelized TetGen remeshing ($p(x)\in[0,1]$6–$p(x)\in[0,1]$7s for $p(x)\in[0,1]$8 million element FE mesh).
• Automated raw DICOM-to-final FE mesh in $p(x)\in[0,1]$9s on a 16-core CPU/64GB RAM workstation; manual workflows require 3–5 hours.
• Smoothing implemented via vectorized NumPy/SciPy solvers, with boundary conditions imposed using sparse matrix masking.

Automation enables high-throughput analysis and supports population-scale cohorts, rapid clinical workflows (e.g., device planning for TAVR), and strict reproducibility across institutions (Pak et al., 2024).

4. Validation and Quantitative Performance

Cohort and Imaging

• $<$0 patients with severe aortic stenosis (0.5–0.8 mm CT slice thickness); $<$1 TAVR (pre/post-intervention) cases used for device validation.

Simulation Setups

• Static pressure drop simulations via incompressible FE flow solver (Reynolds $<$2).
• Quasi-static device deployment (Medtronic CoreValve) using large-strain solid mechanics for TAVR scenarios.

Results Summary

Metric	Automated	Manual
Mean scaled Jacobian $<$3	$<$4	$<$5
Dihedral angles (5th–95th)	$<$6	$<$7 ($<$88% inverted/tiny)
AS $<$9 error	$\phi(x) = p(x)-\tau$0 mmHg ($\phi(x) = p(x)-\tau$18% of peak $\phi(x) = p(x)-\tau$2)	--
TAVR PVL volume diff.	$\phi(x) = p(x)-\tau$3 mL ($\phi(x) = p(x)-\tau$45% of stroke vol)	--

• Automated meshes exhibit substantially improved element quality and no human-induced mesh pathologies.
• Simulation results (pressure gradients, paravalvular leak) demonstrate high-fidelity agreement with manual meshes and clinical expectations (Pak et al., 2024).

5. Integration and Impact on Cardiac Digital Twin Ecosystem

Automated calcification meshing is integrated directly into CDT construction, facilitating:

• Cohort-scale phenotype studies—large-scale calcification analysis for stratifying device/procedure risk.
• Pipeline acceleration—seamless upstream/downstream connection to segmentation, mesh generation, and FE solver modules.
• Clinical reproducibility—standardized process reduces operator-dependent bias in complex anatomic pathologies (e.g., aortic root calcification).
• Real-time applications—emerging feasibility for peri-procedural use in device sizing and procedural risk prediction (Pak et al., 2024).

This advance enables in silico trials, statistical shape analysis, and personalized device testing at population scale.

6. Limitations and Future Directions

Limitations

• Over-smoothing of ultra-thin/diffuse calcifications (sub-2 voxels).
• Challenges in the presence of severe CT metal artifacts—potential need for dual-energy CT or artifact correction.
• Linear elastic assumption for calcification mechanics; anisotropic/damage models not yet implemented.

Ongoing/Future Work

• Incorporation of anisotropic curvature flow for improved preservation of delicate calcification geometry.
• GPU-accelerated meshing and smoothing (parallel marching tetrahedra, CUDA) to reduce runtimes further.
• Extension to material models capturing the anisotropy and failure of calcified nodules.
• Integration with artifact-suppression pipelines and domain-adaptive segmentation (Pak et al., 2024).

7. Conclusion and Significance

Patient-specific, high-fidelity calcification meshing is now achievable in a highly automated, reproducible, and computationally efficient manner—representing a key enabling technology for biomechanically accurate cardiac digital twins. This methodology eliminates the critical bottleneck of operator-dependent, manual mesh workflows, thus accelerating the realization of large-scale, physics-driven simulations for both research and clinical device applications (Pak et al., 2024). The approach provides a robust template for the broader automation and standardization imperative across the CDT ecosystem.